2016 Q4 Form 10-K Financial Statement

#000114420417014986 Filed on March 16, 2017

View on sec.gov

Income Statement

Concept 2016 Q4 2015 Q4 2015 Q3
Revenue $35.00K $0.00 $0.00
YoY Change -100.0% -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.200M $1.120M $790.0K
YoY Change 7.14% 96.49% -9.2%
% of Gross Profit
Research & Development $2.090M $1.140M $1.010M
YoY Change 83.33% -28.75% 29.16%
% of Gross Profit
Depreciation & Amortization $100.0K $90.00K $90.00K
YoY Change 11.11% 12.5% 0.0%
% of Gross Profit
Operating Expenses $3.290M $2.250M $1.802M
YoY Change 46.22% 3.69% 9.28%
Operating Profit -$1.802M
YoY Change 144.17%
Interest Expense $970.0K -$50.00K $0.00
YoY Change -2040.0% -106.49%
% of Operating Profit
Other Income/Expense, Net -$50.00K $0.00 -$5.000K
YoY Change -100.0% -100.34%
Pretax Income -$2.330M -$2.290M -$1.810M
YoY Change 1.75% 387.23% -351.39%
Income Tax
% Of Pretax Income
Net Earnings -$2.327M -$2.294M -$1.807M
YoY Change 1.44% 384.99% -352.37%
Net Earnings / Revenue -6648.57%
Basic Earnings Per Share -$0.11 -$0.11 -$0.09
Diluted Earnings Per Share -$0.15 -$0.11 -$0.09
COMMON SHARES
Basic Shares Outstanding 21.20M shares 20.06M shares 20.06M shares
Diluted Shares Outstanding 20.06M shares

Balance Sheet

Concept 2016 Q4 2015 Q4 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.00M $7.900M $9.700M
YoY Change 77.22% -49.03% 29.33%
Cash & Equivalents $14.01M $7.857M $9.690M
Short-Term Investments
Other Short-Term Assets $200.0K $200.0K $300.0K
YoY Change 0.0% 100.0% 0.0%
Inventory
Prepaid Expenses
Receivables $3.600M $4.213M $3.898M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $17.80M $12.24M $13.85M
YoY Change 45.38% -37.48% 16.39%
LONG-TERM ASSETS
Property, Plant & Equipment $800.0K $1.043M $1.059M
YoY Change -23.3% -17.74% -24.36%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $900.0K $1.043M $1.059M
YoY Change -13.71% -17.74% -18.54%
TOTAL ASSETS
Total Short-Term Assets $17.80M $12.24M $13.85M
Total Long-Term Assets $900.0K $1.043M $1.059M
Total Assets $18.70M $13.29M $14.91M
YoY Change 40.74% -36.28% 12.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.000M $4.158M $4.038M
YoY Change -27.85% -5.67% -8.23%
Accrued Expenses $1.800M $341.0K $206.0K
YoY Change 427.86% 34.25% -58.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $4.857M $4.853M $4.594M
YoY Change 0.08% -27.15% -38.75%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $600.0K $1.400M $1.400M
YoY Change -57.14% -75.0% -6.67%
Total Long-Term Liabilities $0.00 $1.400M $1.400M
YoY Change -100.0% -75.0% -6.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.857M $4.853M $4.594M
Total Long-Term Liabilities $0.00 $1.400M $1.400M
Total Liabilities $5.476M $6.297M $5.992M
YoY Change -13.04% -48.55% -33.42%
SHAREHOLDERS EQUITY
Retained Earnings -$309.0M -$314.1M -$311.8M
YoY Change -1.63% 3.72%
Common Stock $297.9M $297.8M
YoY Change 0.01% 2.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.19M $6.990M $8.917M
YoY Change
Total Liabilities & Shareholders Equity $18.67M $13.29M $14.91M
YoY Change 40.49% -36.28% 12.95%

Cashflow Statement

Concept 2016 Q4 2015 Q4 2015 Q3
OPERATING ACTIVITIES
Net Income -$2.327M -$2.294M -$1.807M
YoY Change 1.44% 384.99% -352.37%
Depreciation, Depletion And Amortization $100.0K $90.00K $90.00K
YoY Change 11.11% 12.5% 0.0%
Cash From Operating Activities -$2.410M -$1.760M -$1.760M
YoY Change 36.93% 11.39% 26.62%
INVESTING ACTIVITIES
Capital Expenditures -$70.00K -$70.00K -$50.00K
YoY Change 0.0% 400.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$70.00K -$70.00K -$50.00K
YoY Change 0.0% 400.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -2.410M -1.760M -1.760M
Cash From Investing Activities -70.00K -70.00K -50.00K
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash -2.480M -1.830M -1.810M
YoY Change 35.52% -122.82% 29.29%
FREE CASH FLOW
Cash From Operating Activities -$2.410M -$1.760M -$1.760M
Capital Expenditures -$70.00K -$70.00K -$50.00K
Free Cash Flow -$2.340M -$1.690M -$1.710M
YoY Change 38.46% 6.96% 23.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1444000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-314099000 USD
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24300000 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23261000 USD
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
297855000 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
297828000 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-11279000 USD
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
4512000 USD
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20053000 shares
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20053000 shares
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4857000 USD
CY2016Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
619000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4853000 USD
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20744000 shares
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21459000 shares
CY2016 us-gaap Net Income Loss
NetIncomeLoss
5135000 USD
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-825000 USD
CY2014 us-gaap Licenses Revenue
LicensesRevenue
3646000 USD
CY2014 us-gaap Revenues
Revenues
3646000 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
7121000 USD
CY2014 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1083000 USD
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17060000 shares
CY2016 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
37000 USD
CY2015 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
0 USD
CY2014 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
0 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-3475000 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-2403000 USD
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17057000 shares
CY2015Q4 us-gaap Liabilities
Liabilities
6297000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18667000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13287000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
13191000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
6990000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-308964000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
5476000 USD
CY2016 ttnp Incremental Common Shares Attributable To Assumed Exercise Of Warrants
IncrementalCommonSharesAttributableToAssumedExerciseOfWarrants
574000 shares
CY2016 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5135000 USD
CY2015 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11279000 USD
CY2014 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3486000 USD
CY2014 ttnp Incremental Common Shares Attributable To Assumed Exercise Of Warrants
IncrementalCommonSharesAttributableToAssumedExerciseOfWarrants
0 shares
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1679000 shares
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1286000 shares
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1577000 shares
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8000 USD
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
5760000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
8611000 USD
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4747000 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
543000 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1026000 USD
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1039000 USD
CY2015 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
14000 USD
CY2014 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
36000 USD
CY2015 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
8646000 USD
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
27000 USD
CY2016 ttnp Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
0 USD
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
377000 USD
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
358000 USD
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
1039000 USD
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-626000 USD
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
63000 USD
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1671000 USD
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
6293000 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-7466000 USD
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
171000 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
133000 USD
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-171000 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-133000 USD
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
27000 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-14000 USD
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6149000 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7613000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15470000 USD
CY2016 ttnp Stock Issued From Vesting Of Restricted Stock
StockIssuedFromVestingOfRestrictedStock
0 USD
CY2015 ttnp Stock Issued From Vesting Of Restricted Stock
StockIssuedFromVestingOfRestrictedStock
14000 USD
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
353000 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
543000 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-850000 USD
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-59000 USD
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3646000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5865000 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18000 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-18000 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
9555000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11798000 USD
CY2014 ttnp Stock Issued From Vesting Of Restricted Stock
StockIssuedFromVestingOfRestrictedStock
36000 USD
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
27000 USD
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2016 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
CY2015 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
CY2014 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
9591000 USD
CY2016 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1147000 USD
CY2015 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
112000 USD
CY2016 ttnp Incremental Common Shares Attributable To Assumed Exercise Of Options
IncrementalCommonSharesAttributableToAssumedExerciseOfOptions
141000 shares
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11279000 USD
CY2014 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2403000 USD
CY2015 ttnp Incremental Common Shares Attributable To Assumed Exercise Of Warrants
IncrementalCommonSharesAttributableToAssumedExerciseOfWarrants
0 shares
CY2014 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
172000 USD
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1143000 USD
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-250000 USD
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-710000 USD
CY2016Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
14000000 USD
CY2016 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
4310000 USD
CY2015 ttnp Incremental Common Shares Attributable To Assumed Exercise Of Options
IncrementalCommonSharesAttributableToAssumedExerciseOfOptions
0 shares
CY2014 ttnp Incremental Common Shares Attributable To Assumed Exercise Of Options
IncrementalCommonSharesAttributableToAssumedExerciseOfOptions
3000 shares
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5100000 USD
CY2016Q4 ttnp Class Of Warrants Fair Value Disclosure
ClassOfWarrantsFairValueDisclosure
619000 USD
CY2015Q4 ttnp Class Of Warrants Fair Value Disclosure
ClassOfWarrantsFairValueDisclosure
1444000 USD
CY2014Q4 ttnp Class Of Warrants Fair Value Disclosure
ClassOfWarrantsFairValueDisclosure
5578000 USD
CY2016 ttnp Reclassification Of Underwriter Warrant
ReclassificationOfUnderwriterWarrant
0 USD
CY2015 ttnp Reclassification Of Underwriter Warrant
ReclassificationOfUnderwriterWarrant
8646000 USD
CY2016 ttnp Change In Fair Value Of Warrants
ChangeInFairValueOfWarrants
-825000 USD
CY2015 ttnp Change In Fair Value Of Warrants
ChangeInFairValueOfWarrants
4512000 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3642000 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3265000 USD
CY2015 ttnp Expense Incurred Under Research And License Agreements
ExpenseIncurredUnderResearchAndLicenseAgreements
3000 USD
CY2016 ttnp Maximum Amount Eligible To Be Received On Achievement Of Sales Milestone
MaximumAmountEligibleToBeReceivedOnAchievementOfSalesMilestone
15000000 USD
CY2016 ttnp Maximum Amount Eligible To Be Received On Achievement Of Regulatory Milestone
MaximumAmountEligibleToBeReceivedOnAchievementOfRegulatoryMilestone
15000000 USD
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
257000 USD
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
211000 USD
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
209000 USD
CY2013Q1 ttnp Gains Losses On Extinguishment Of Royalty Liability
GainsLossesOnExtinguishmentOfRoyaltyLiability
9000000 USD
CY2016 ttnp Notional Liquidation Damages
NotionalLiquidationDamages
2500000 USD
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 ttnp Underwritten Public Offering Proceeds From Units Issued
UnderwrittenPublicOfferingProceedsFromUnitsIssued
9600000 USD
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1039000 USD
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1026000 USD
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
543000 USD
CY2016 ttnp Share Based Compensation Expense Impact On Basic Earnings Per Share
ShareBasedCompensationExpenseImpactOnBasicEarningsPerShare
0.05
CY2015 ttnp Share Based Compensation Expense Impact On Basic Earnings Per Share
ShareBasedCompensationExpenseImpactOnBasicEarningsPerShare
0.05
CY2014 ttnp Share Based Compensation Expense Impact On Basic Earnings Per Share
ShareBasedCompensationExpenseImpactOnBasicEarningsPerShare
0.03
CY2016 ttnp Share Based Compensation Expense Impact On Diluted Earnings Per Share
ShareBasedCompensationExpenseImpactOnDilutedEarningsPerShare
0.05
CY2015 ttnp Share Based Compensation Expense Impact On Diluted Earnings Per Share
ShareBasedCompensationExpenseImpactOnDilutedEarningsPerShare
0.05
CY2014 ttnp Share Based Compensation Expense Impact On Diluted Earnings Per Share
ShareBasedCompensationExpenseImpactOnDilutedEarningsPerShare
0.03
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0153 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0188 pure
CY2016 ttnp Estimated Forfeiture Rates For Options Granted To Management
EstimatedForfeitureRatesForOptionsGrantedToManagement
0.29 pure
CY2015 ttnp Estimated Forfeiture Rates For Options Granted To Management
EstimatedForfeitureRatesForOptionsGrantedToManagement
0.3 pure
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y6M11D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y5M23D
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.0092 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.0116 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0204 pure
CY2014 ttnp Estimated Forfeiture Rates For Options Granted To Management
EstimatedForfeitureRatesForOptionsGrantedToManagement
0.31 pure
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y5M16D
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.0165 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.10
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.67
CY2016 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P10M17D
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
87267000 USD
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
91365000 USD
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2637000 USD
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3417000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
14322000 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
13884000 USD
CY2015Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
0 USD
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
104226000 USD
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2016Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
0 USD
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1758000 USD
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3840000 USD
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-268000 USD
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
108666000 USD
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
104226000 USD
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
108666000 USD
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2014 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
592000 USD
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-839000 USD
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-187000 USD
CY2016 ttnp Income Tax Reconciliation Book Gains Losses Not Currently Benefited
IncomeTaxReconciliationBookGainsLossesNotCurrentlyBenefited
-4439000 USD
CY2015 ttnp Income Tax Reconciliation Book Gains Losses Not Currently Benefited
IncomeTaxReconciliationBookGainsLossesNotCurrentlyBenefited
2740000 USD
CY2014 ttnp Income Tax Reconciliation Book Gains Losses Not Currently Benefited
IncomeTaxReconciliationBookGainsLossesNotCurrentlyBenefited
454000 USD
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
659000 USD
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-20000 USD
CY2014 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
235000 USD
CY2016 ttnp Income Tax Reconciliation Revaluation Of Warrant Liability
IncomeTaxReconciliationRevaluationOfWarrantLiability
-280000 USD
CY2015 ttnp Income Tax Reconciliation Revaluation Of Warrant Liability
IncomeTaxReconciliationRevaluationOfWarrantLiability
1534000 USD
CY2014 ttnp Income Tax Reconciliation Revaluation Of Warrant Liability
IncomeTaxReconciliationRevaluationOfWarrantLiability
-346000 USD
CY2016 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
252000 USD
CY2015 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
146000 USD
CY2014 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
97000 USD
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1000 USD
CY2016 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
4400000 USD
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2700000 USD
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
500000 USD
CY2015Q1 us-gaap Revenues
Revenues
911000 USD
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-2294000 USD
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-2281000 USD
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2015Q2 us-gaap Revenues
Revenues
760000 USD
CY2015Q3 us-gaap Revenues
Revenues
0 USD
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2016Q2 us-gaap Revenues
Revenues
15004000 USD
CY2016Q3 us-gaap Revenues
Revenues
26000 USD
CY2016Q4 us-gaap Revenues
Revenues
35000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-1846000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
11928000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-2620000 USD
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-2327000 USD
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.58
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2016 dei Document Type
DocumentType
10-K
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016 dei Entity Registrant Name
EntityRegistrantName
TITAN PHARMACEUTICALS INC
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0000910267
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2016Q2 dei Entity Public Float
EntityPublicFloat
113100000 USD
CY2016 dei Trading Symbol
TradingSymbol
TTNP
CY2017Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21198879 shares
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21198879 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21198879 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20059820 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20059820 shares
CY2016Q2 us-gaap Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
15000000 USD
CY2016 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 5.5 reverse stock split effected in September 2015
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4479000 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4308000 USD
CY2014 ttnp Expense Incurred Under Research And License Agreements
ExpenseIncurredUnderResearchAndLicenseAgreements
3000 USD
CY2015Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
0 USD
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 12.2pt"> <strong><i>Use of Estimates</i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 12.2pt"> <strong>&#160;</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
277000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
287000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
299000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
308000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
155000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1326000 USD
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1831000 shares
CY2016Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
3833000 shares
CY2015Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
Board effected the Reverse Split of the outstanding shares of our common stock at a ratio of one (1) share for every five and one-half (5.5) shares outstanding, so that every five and one-half (5.5) outstanding shares of common stock before the Reverse Split represents one (1) share of common stock after the Reverse Split.
CY2016 ttnp Effective Income Tax Rate Reconciliation Deduction Net Operating Loss Carryforward Expirations
EffectiveIncomeTaxRateReconciliationDeductionNetOperatingLossCarryforwardExpirations
-2741000 USD
CY2015 ttnp Effective Income Tax Rate Reconciliation Deduction Net Operating Loss Carryforward Expirations
EffectiveIncomeTaxRateReconciliationDeductionNetOperatingLossCarryforwardExpirations
0 USD
CY2014 ttnp Effective Income Tax Rate Reconciliation Deduction Net Operating Loss Carryforward Expirations
EffectiveIncomeTaxRateReconciliationDeductionNetOperatingLossCarryforwardExpirations
0 USD
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2016Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
2002000 shares
CY2016 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P5Y8M5D
CY2016Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
5.67
CY2016Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1709000 shares
CY2016Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
5.77
CY2016 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
2.47
CY2016 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
17.21
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.52
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
825000 USD
CY2015 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4512000 USD
CY2014 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1083000 USD
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11300000 USD
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2400000 USD
CY2012 invest Investment Warrants Expiration Date
InvestmentWarrantsExpirationDate
2012-10-31
CY2016Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
13700000 USD
CY2015Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
7600000 USD
CY2014Q4 ttnp Underwritten Public Offering Description Of Units Issued
UnderwrittenPublicOfferingDescriptionOfUnitsIssued
consisting of one share of common stock and 0.75 of a warrant (&#8220;Class A Warrant&#8221;)

Files In Submission

Name View Source Status
0001144204-17-014986-index-headers.html Edgar Link pending
0001144204-17-014986-index.html Edgar Link pending
0001144204-17-014986.txt Edgar Link pending
0001144204-17-014986-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ttnp-20161231.xml Edgar Link completed
ttnp-20161231.xsd Edgar Link pending
ttnp-20161231_cal.xml Edgar Link unprocessable
ttnp-20161231_def.xml Edgar Link unprocessable
ttnp-20161231_lab.xml Edgar Link unprocessable
ttnp-20161231_pre.xml Edgar Link unprocessable
v461168_10k.htm Edgar Link pending
v461168_ex23-1.htm Edgar Link pending
v461168_ex31-1.htm Edgar Link pending
v461168_ex32-1.htm Edgar Link pending